First-lineEltroxin
Levothyroxine
Synthetic thyroid hormone (T4)
Hypothyroidism in pregnancy — increase dose early, monitor TSH q4–6 wks.
Oral
First-line for
- Pre-existing hypothyroidism
- Subclinical hypothyroidism with TPO antibodies
Mechanism
Replaces endogenous T4 → converted to active T3 → nuclear receptor signalling → metabolic regulation.
“+30% by +6”
- Increase dose ~25–30% as soon as pregnancy confirmed
- Recheck TSH at 6 weeks (and q4–6 weekly)
- Target TSH <2.5 mIU/L T1; <3 mIU/L T2/T3
- Return to pre-pregnancy dose immediately postpartum
Dosing
- Pre-existing
- ↑ existing dose by 25–30% on positive test
- New diagnosis
- 1.6–2.0 mcg/kg/day
Contraindications
- AbsoluteUntreated thyrotoxicosis, adrenal insufficiency
Side effects
- Palpitations, tremor (overdose)
- Insomnia, weight loss (overdose)
- Reduced bone density (chronic over-replacement)
Fetal & maternal notes
- • Crosses placenta minimally — but maternal hypothyroidism causes ↓ fetal IQ.
- • Safe in breastfeeding.
Key interactions
Iron, calcium, PPIs
Caution↓ absorption — separate by ≥4 h
Oestrogen (HRT)
Caution↑ TBG → may need ↑ dose
Clinical pearls
- 💡 Take fasting, 30–60 min before breakfast.
- 💡 Iodine supplementation in pregnancy 150 mcg/day.
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.